as 05-21-2024 10:33am EST
Since its founding in 1806, Colgate-Palmolive has grown to become a leading player in the household and personal care arena. In addition to its namesake oral care line, the firm manufactures shampoos, shower gels, deodorants, and homecare products that are sold in over 200 countries. International sales account for about 70% of its total business, including approximately 45% from emerging regions. It also owns specialty pet food maker Hill's, which primarily sells its products through veterinarians and specialty pet retailers.
Founded: | 1806 | Country: | United States |
Employees: | N/A | City: | NEW YORK |
Market Cap: | 77.6B | IPO Year: | N/A |
Target Price: | $93.38 | AVG Volume (30 days): | 4.1M |
Analyst Decision: | Strong Buy | Number of Analysts: | 16 |
Dividend Yield: | 2.12% | Dividend Payout Frequency: | Quarterly |
EPS: | 3.16 | EPS Growth: | 64.58 |
52 Week Low/High: | $67.62 - $95.59 | Next Earning Date: | 04-26-2024 |
Revenue: | $19,752,000,000 | Revenue Growth: | 7.71% |
Revenue Growth (this year): | 6.82% | Revenue Growth (next year): | 4.28% |
Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Massey Sally | CL | Chief Human Resources Officer | May 1 '24 | Sell | $91.92 | 6,115 | $562,090.80 | 13,924 | SEC Form 4 |
Parameswaran Prabha | CL | Grp Pres, Growth & Strategy | Feb 15 '24 | Sell | $84.02 | 56,836 | $4,775,377.77 | 18,681 | SEC Form 4 |
Wallace Noel R. | CL | Chairman, President & CEO | Feb 15 '24 | Sell | $84.06 | 29,772 | $2,502,664.09 | 301,343 | SEC Form 4 |
Wallace Noel R. | CL | Chairman, President & CEO | Feb 15 '24 | Sell | $84.41 | 14,462 | $1,220,802.50 | 342,367 | SEC Form 4 |
Wallace Noel R. | CL | Chairman, President & CEO | Feb 15 '24 | Sell | $84.17 | 55,486 | $4,670,084.61 | 286,881 | SEC Form 4 |
Wallace Noel R. | CL | Chairman, President & CEO | Feb 12 '24 | Sell | $83.15 | 50,000 | $4,157,280.00 | 274,179 | SEC Form 4 |
Kooyman John W | CL | Chief of Staff | Feb 9 '24 | Sell | $83.60 | 21,023 | $1,757,457.63 | 5,282 | SEC Form 4 |
Malcolm Gregory | CL | EVP and Controller | Feb 1 '24 | Sell | $85.35 | 8,930 | $762,184.43 | 8,043 | SEC Form 4 |
Daniels Jennifer | CL | CLO and Secretary | Feb 1 '24 | Sell | $83.93 | 61,633 | $5,172,697.44 | 57,948 | SEC Form 4 |
HARRIS C MARTIN | CL | Director | Jan 31 '24 | Sell | $84.50 | 2,760 | $233,220.00 | 19,272 | SEC Form 4 |
Tsourapas Panagiotis | CL | Grp Pres, Eur& Developing Mkts | Jan 31 '24 | Sell | $84.41 | 30,433 | $2,568,706.49 | 12,126 | SEC Form 4 |
Daniels Jennifer | CL | CLO and Secretary | Nov 30 '23 | Sell | $79.01 | 3,800 | $300,219.38 | 58,193 | SEC Form 4 |
Tsourapas Panagiotis | CL | Grp Pres, Eur& Developing Mkts | Nov 28 '23 | Sell | $77.83 | 15,000 | $1,167,409.50 | 12,371 | SEC Form 4 |
Tsourapas Panagiotis | CL | Grp Pres, Eur& Developing Mkts | Nov 10 '23 | Sell | $75.36 | 20,000 | $1,507,186.00 | 12,292 | SEC Form 4 |
CL Breaking Stock News: Dive into CL Ticker-Specific Updates for Smart Investing
Investing.com
17 hours ago
Zacks
a day ago
Zacks
a day ago
Investing.com
4 days ago
MT Newswires
5 days ago
Zacks
5 days ago
Zacks
6 days ago
Argus Research
6 days ago